Table 5: Description of Failed Challenge Reactions.
Overall (n=30) |
Grade 2/3 Reaction (n=21) |
Anaphylactic Reaction (n=3) |
|
---|---|---|---|
Percent Ingested, mean (sd) | 37.0 (38.3) | 39.8 (41.8) | 57.0 (60.8) |
Reaction Symptoms: Subjective | |||
Oral Itching | 8 (27%) | 3 (14%) | 0 (0%) |
Pruritus | 8 (27%) | 6 (29%) | 1 (33%) |
Nausea | 2 (7%) | 2 (10%) | 0 (0%) |
Abdominal Pain | 3 (10%) | 3 (14%) | 1 (33%) |
Irritability | 2 (7%) | 2 (10%) | 0 (0%) |
Dizziness | 0 (0%) | 0 (0%) | 0 (0%) |
Reaction Symptoms: Objective | |||
Hives / Angioedema | 17 (57%) | 17 (81%) *** | 2 (67%) |
Non-urticarial Rash | 3 (10%) | 1 (5%) | 0 (0%) |
Flushing (local) | 6 (20%) | 3 (14%) | 1 (33%) |
Flushing (generalized) | 0 (0%) | 0 (0%) | 0 (0%) |
Nasal symptoms | 12 (40%) | 10 (48%) | 3 (100%) |
Wheeze | 2 (7%) | 2 (10%) | 2 (67%)* |
Laryngeal symptoms† | 1 (3%) | 1 (5%) | 0 (0%) |
Vomiting | 3 (10%) | 3 (14%) | 1 (33%) |
Diarrhea | 0 (0%) | 0 (0%) | 0 (0%) |
Tachycardia | 1 (3%) | 1 (5%) | 1 (33%) |
Low blood pressure | 0 (0%) | 0 (0%) | 0 (0%) |
Reaction Treatment | |||
Treatment given | 21 (70%) | 14 (67%) | 3 (100%) |
Antihistamines | 21 (70%) | 14 (67%) | 3 (100%) |
H2 blocker | 3 (10%) | 3 (14%) | 2 (67%)* |
Steroid | 2 (7%) | 2 (10%) | 2 (67%)* |
Albuterol | 1 (3%) | 1 (5%) | 1 (33%) |
Epinephrine | 2 (7%) | 2 (10%) | 2 (67%)* |
In this cohort, the 1 subject experiencing laryngeal symptoms had throat clearing.
p<0.05
p<0.01
p<0.001